GlaxoSmithKline and Genmab's Arzerra receives marketing authorisation from European Commission
GlaxoSmithKline and Genmab's Arzerra receives marketing authorisation from European Commission
About this item
Full title
GlaxoSmithKline and Genmab's Arzerra receives marketing authorisation from European Commission
Publisher
London: Normans Media Ltd
Journal title
M2 Pharma, 2014
Language
English
Formats
Publication information
Publisher
London: Normans Media Ltd
Subjects
More information
Scope and Contents
Contents
M2PHARMA-July 7, 2014-GlaxoSmithKline and Genmab's Arzerra receives marketing authorisation from European Commission (C)2014 M2 COMMUNICATIONS http://www.m2.com GlaxoSmithKline and Genmab's Arzerra has received marketing authorisation from the European Commission for use as first-line treatment for ch...
Alternative Titles
Full title
GlaxoSmithKline and Genmab's Arzerra receives marketing authorisation from European Commission
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_1543265497
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1543265497
How to access this item
Log in as a Library member
